Palmoplantar Erythrodysesthesia-Like Skin Symptoms in Patients under Various Chemotherapeutics: Preventive and Therapeutic Options

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Skin Pharmacology and Physiology

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000356780PMID 24802288
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficient Prevention Strategy against the Development of a Palmar-Plantar Erythrodysesthesia during Chemotherapy

  2013cited by this paper
• Pathogenesis of Hand-Foot Syndrome induced by PEG-modified liposomal Doxorubicin

  2013cited by this paper
• Cutaneous side effects of new antitumor drugs: clinical features and management.

  2012cited by this paper
• Prevention of palmoplantar erythrodysesthesia (PPE) with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (PLD), a placebo-controlled, double blinded, phase lll trial (SAKK 92/08).

  2012cited by this paper
• The hand‐foot‐syndrome associated with medical tumor therapy – classification and management

  2010cited by this paper
• The pathogenetic mechanism of anthracycline-induced palmar-plantar erythrodysesthesia.

  2009cited by this paper
• Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study

  2008cited by this paper
• Detection of Doxorubicin in the Horny Layer in a Patient Suffering from Palmar-Plantar Erythrodysaesthesia

  2005cited by this paper
• Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?

  2005cited by this paper
• The effect of regional cooling on toxicity associated with intravenous infusion of pegylated liposomal doxorubicin in recurrent ovarian carcinoma.

  2004cited by this paper
• Current Canadian Experience With Capecitabine: Partnering With Patients to Optimize Therapy

  2003cited by this paper
• Antineoplastic Therapy—Induced Palmar Plantar Erythrodysesthesia (‘Hand-Foot’) Syndrome

  2000cited by this paper
• Number of cell layers of the stratum corneum in normal skin – relationship to the anatomical location on the body, age, sex and physical parameters

  1999cited by this paper
• Classification of cosmetic products : The radical protection factor (RPF)

  1998cited by this paper
• Hand‐foot syndrome following prolonged infusion of high doses of vinorelbine

  1998cited by this paper
• Hand‐foot syndrome associated with liposome‐encapsulated doxorubicin therapy

  1995cited by this paper
• Treatment of cytarabine acral erythema with corticosteroids.

  1991cited by this paper
• Fluorouracil and the palmar-plantar erythrodysesthesia syndrome.

  1985cited by this paper

• Influence of Sorafenib, Sunitinib and Capecitabine on the Antioxidant Status of the Skin

  2018cites this paper
• The influence of chemotherapy and lifestyle on the antioxidative status of human skin

  2018cites this paper
• Prevention of palmoplantar erythrodysesthesia in patients treated with pegylated liposomal doxorubicin (Caelyx®)

  2017cites this paper
• Strategies for Prevention and Treatment of Chemotherapy-Induced Hand-Foot- Skin-Reaction (HFSR)

  2016cites this paper
• Influence of Chemotherapy on the Antioxidant Status of Human Skin.

  2016cites this paper
• Detection of capecitabine (Xeloda®) on the skin surface after oral administration

  2016cites this paper
• Gestion des effets secondaires cutanés des chimiothérapies et thérapies ciblées

  2015cites this paper
• Influence of Mechanical Stress on Palmoplantar Erythrodysesthesia - a Case Report

  2015cites this paper
• The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia

  2015cites this paper
• [Management of the cutaneous side effects of chemotherapies and targeted therapies].

  2015cites this paper
• Aktuelle Entwicklungen in der Prävention und Therapie des Hand- und Fußsyndroms

  2015cites this paper